In addition, the inhibition of endogenous RUNX1 using short-hairpin RNA targeting RUNX1 (shRunx1) in breast cancer cells resulted in loss of epithelial morphology and promotion of epithelial-mesenchymal transition [9], and the ectopic expression of RUNX1 reduced the population of breast cancer stem cells [21]. Here, RUNX1 is linked to breast cancer.